King, B., Lee, A. I., & Choi, J. (2016). Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. J Invest Dermatol.
Citação norma ChicagoKing, Brett, Alfred Ian Lee, and Jaehyuk Choi. "Treatment of Hypereosinophilic Syndrome With Cutaneous Involvement With the JAK Inhibitors Tofacitinib and Ruxolitinib." J Invest Dermatol 2016.
MLA citiranjeKing, Brett, Alfred Ian Lee, and Jaehyuk Choi. "Treatment of Hypereosinophilic Syndrome With Cutaneous Involvement With the JAK Inhibitors Tofacitinib and Ruxolitinib." J Invest Dermatol 2016.
Opozorilo: Ti citati niso vedno 100% točni.